GPT and cancer: However, cancer cells can elongate their telomeres and regain telomere stability by activating one of two known telomere maintenance mechanisms (TMMs)—telomerase, which is activated in 85–90% of cancers; or the alternative lengthening of telomeres (ALT) mechanism (10–15% of cancers), which is often present in cancer cells that do not express telomerase [194].